Cesentyx becomes a new psoriasis treatment option

The industry has attracted attention if Novartis’s Cosentyx(generic name: secukinumab) will deliver a new treatment option to severe psoriasis patients.

Last September, Novartis’s Cosentyx acquired approval as a severe plaque psoriasis for adults, who require phototherapy and whole body therapy(treatment which spreads medicine in the whole body as absorbed to it), from the Ministry of Food and...